MSJ-650

N/A

Report date: 2024/07/05 13:45:27

Base Information

Drug NameMSJ-650
Drug Alias NameMSJ-650MSJ650
ClassificationBiologics > Oncolytic virusCell and gene therapy > Cell therapy > Immune system cell therapy
Mechanisms of ActionCell death stimulantsImmunologic cytotoxicity
TargetsNot applicable
Therapy Area/IndicationsColorectal NeoplasmsBreast NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSillajen Biotherapeutics Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsColorectal NeoplasmsBreast Neoplasms
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A